Niklas Hartmann

Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells.

J R Ballinger, J. Bannerman, IZZIE BOXEN et al. · PubMed · 1996 · 131 citations

Effects of the D2 Receptor Agonist Bromocriptine on Sleep Bruxism: Report of Two Single-patient Clinical Trials

Frank Lobbezoo, Jean‐Paul Soucy, Niklas Hartmann et al. · Journal of Dental Research · 1997 · 98 citations

Binding of actinomycin D to DNA: evidence for a nonclassical high-affinity binding mode that does not require GpC sites.

James G. Snyder, Niklas Hartmann, B L D'Estantoit et al. · Proceedings of the National Academy of Sciences · 1989 · 64 citations · Full text

Actinomycin D, Nucleic Acid Chemistry, Gpc Sites +9

<i>In vivo</i> inhibition of <i>β</i>-glucosidase and <i>β</i>-mannosidase activity in rats by 2-deoxy-2-fluoro-<i>β</i>-glycosyl fluorides and recovery of activity <i>in vivo</i> and <i>in vitro</i>

John D. McCarter, M.J. Adam, Niklas Hartmann et al. · Biochemical Journal · 1994 · 26 citations · Full text

-Beta-mannosyl Fluorides, Biochemistry, Medicine +9

Substituted amylose as a matrix for sustained-drug release: a biodegradation study

C. Chebli, L. Cartilier, Niklas Hartmann · International Journal of Pharmaceutics · 2001 · 24 citations

Biotechnology, Polysaccharide, Biodegradation Study +3